Project Number 5P50AG005134-29 Agency/Funding Organization NIA Funding Year 2012 View Full Project Details for IMPLICATIONS OF AMYLOID DEPOSITION IN CLINICALLY NORMAL OLDER INDIVIDUALS Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 2. Imaging Biomarkers a. PET Amyloid Imaging Category F. Research Resources 1. Alzheimer's Disease Centers Researcher and Organization Principal Investigator SPERLING, REISA A. Principal Investigator First Name REISA A. Principal Investigator Last Name SPERLING Awardee Organization MASSACHUSETTS GENERAL HOSPITAL Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-09-001: ALZHEIMER'S DISEASE RESEARCH CENTERS (P50) FY Overall Cost $166,780 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PHELPS, CREIGHTON H. Related Resources Repository [NIAGADS] Transethnic GWAS Summary Statistics - Jun et al. (2017) [NIAGADS] ADC3- Alzheimer Disease Center Dataset 3 [NIAGADS] ADGC African American Summary Statistics- Reitz et al. (2013) [NIAGADS] ADGC Neuropath Summary Stats and Phenotypes- Beecham et al. (2014) [NIAGADS] ADGC Summary Statistics- Naj et al. (2011) [NIAGADS] ADC1- Alzheimer Disease Center Dataset 1 [NIAGADS] ADC2- Alzheimer Disease Center Dataset 2 Massachusetts General Hospital/Harvard Medical School Alzheimer's Disease Research Center National Alzheimer's Coordinating Center (NACC) [AlzPED] Methylene blue does not reverse existing neurofibrillary tangle pathology in the rTg4510 mouse model of tauopathy Pagination Page 1 Next page ››
